The partnership will integrate Ocuco’s optical software solution, Acuitas 3, with Nextech’s Ophthalmic Platform.

A study analyzed the geographic and institutional disparities in clinical trial distribution for candidates targeting the ...

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to ...

Researchers from the Czech Republic found that an AI system showed higher sensitivity and specificity for screening diabetic ...

Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health ...

The announcement follows the decision to discontinue the COAST and ShORe trials in wet age-related macular degeneration after ...

BRIMOCHOL PF’s combination of brimonidine and carbachol produces a “pinhole effect,” which is intended to improve depth of ...

Although it improved interdisciplinary communication, ongoing review and safety monitoring are necessary for successful ...

The US Food and Drug Administration (FDA) has accepted the resubmission of the Biologics License Application (BLA) for ...

Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain.

With a range of treatments available for presbyopia, the challenge for clinicians is to guide patients toward the most ...

Nordic Pharma plans to announce commercialization details in the near future for the dry eye disease treatment ...